LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

Home・Elenco Azioni・Phreesia Inc

Phreesia Inc

Chiusa

SettoreSettore sanitario

9.11 -1.94

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

8.96

Massimo

9.33

Metriche Chiave
By Trading Economics
Entrata	657K 3M
Vendite	3.9M 131M
P/E Media del settore	59.625 49.052
EPS	0.187
Margine di Profitto	2.263
Dipendenti	1,789
EBITDA	12M 17M

Raccomandazioni
By TipRanks
Raccomandazioni	Acquista
Previsioni per 12 mesi	+54.25% upside

Dividendi
By Acuity
Utili prossimi	3 set 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	39M 590M
Apertura precedente	11.05
Chiusura precedente	9.11

Notizie sul Sentiment di mercato

By Acuity

58%

42%

271 / 344 Classifica in Healthcare

Phreesia Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

10 giu 2026, 23:36 UTC

Correction to Oracle Reports Higher 4Q Profit Article

10 giu 2026, 23:19 UTC

Stocks to Watch: Oracle, Oxford Industries, Humacyte, PureCycle Technologies

10 giu 2026, 23:09 UTC

PureCycle Technologies Slides on Offerings of Stock and Convertible Notes

10 giu 2026, 23:04 UTC

Oracle Reports Higher 4Q Profit on Surging Cloud Revenue -- Update

10 giu 2026, 20:44 UTC

Caterpillar Raises Quarterly Dividend 8%

10 giu 2026, 23:49 UTC

Elliott: Northern Star Should Take No Options Off The Table

10 giu 2026, 23:48 UTC

Elliott: Reiterates Call For Formal Strategic Review of Northern Star

10 giu 2026, 23:48 UTC

Elliott: Northern Star Board Must Be Substantially Strengthened Beyond 1 Additional Director

10 giu 2026, 23:47 UTC

Nintendo's Stock Recovery Likely Deferred Without Mario Game -- Market Talk

10 giu 2026, 23:47 UTC

Elliott: Board Letter Indicates It Doesn't Understand Magnitude of Change Required

10 giu 2026, 23:46 UTC

Elliott Investment Management: Northern Star Letter Validates Investment Thesis

10 giu 2026, 23:38 UTC

Global Equities Roundup: Market Talk

10 giu 2026, 23:38 UTC

Global Forex and Fixed Income Roundup: Market Talk

10 giu 2026, 23:38 UTC

Nikkei Likely to Fall on Renewed Concerns About Iran Conflict -- Market Talk

10 giu 2026, 23:32 UTC

Oil Rises Amid Escalating Supply-Disruption Fears -- Market Talk

10 giu 2026, 23:20 UTC

Wesfarmers's Bunnings Business Looks Resilient to Macro Headwinds -- Market Talk

10 giu 2026, 22:05 UTC

Correction to Bank of Canada Stays on Hold Market Talk

10 giu 2026, 21:57 UTC

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10 giu 2026, 21:52 UTC

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10 giu 2026, 21:35 UTC

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10 giu 2026, 21:22 UTC

Oracle Stock Slides on Increased Capital Spending -- WSJ

10 giu 2026, 20:50 UTC

Tech, Media & Telecom Roundup: Market Talk

10 giu 2026, 20:50 UTC

Financial Services Roundup: Market Talk

10 giu 2026, 20:50 UTC

Basic Materials Roundup: Market Talk

10 giu 2026, 20:50 UTC

Health Care Roundup: Market Talk

10 giu 2026, 20:39 UTC

Oracle Needs to Raise Less Capital to Fund Data-Center Buildout -- Market Talk

10 giu 2026, 20:34 UTC

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10 giu 2026, 20:33 UTC

This 'Amazon for Travel' Firm Beat Earnings Expectations. The Stock Is Soaring. -- Barrons.com

10 giu 2026, 20:33 UTC

Global Equities Roundup: Market Talk

10 giu 2026, 20:33 UTC

Oracle Health Expected to Grow Double-Digits This Fiscal Year -- Market Talk

Confronto tra pari

Modifica del prezzo

Phreesia Inc Previsione

Obiettivo di Prezzo

By TipRanks

54.25% in crescita

Previsioni per 12 mesi

Media 14.33 USD 54.25%

Alto 20 USD

Basso 9 USD

Basato su 18 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Phreesia Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

18 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 18 che hanno fornito valutazioni azionarie a Phreesia Inc - Dist negli ultimi 3 mesi.

Sentiment

By Acuity

271 / 344 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Phreesia Inc

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.